The Children's Hospital of Philadelphia

The Children's Hospital of Philadelphia (CHOP) is a privately-held, charitable 501(c)(3) nonprofit organization headquartered in Philadelphia, Pennsylvania. Established in 1855, it holds the distinction of being the first hospital in the United States dedicated exclusively to pediatrics. Its mission is to be a world leader in advancing healthcare for children by integrating excellent patient care, innovative research, and quality professional education into all its programs.

CHOP offers a comprehensive spectrum of top-ranked pediatric care, addressing conditions from routine to rare. Services include emergency care, urgent care, primary care, specialty care across more than 15 centers, and inpatient services. The institution operates two main hospital locations in Philadelphia and King of Prussia, alongside a network of care sites throughout Pennsylvania and New Jersey. A significant focus is placed on innovative research, particularly in areas such as gene therapy, sickle cell disease, hemophilia A, and personalized medicine.

Under the leadership of CEO Madeline Bell, who has served for nearly a decade, CHOP consistently ranks among the best children's hospitals nationally by U.S. News & World Report and was recognized as No. 1 on Forbes' 2022 list of America's Best Large Employers. Recent notable developments include pioneering contributions to gene therapy, strategic collaborations for advanced pediatric diagnostics, and the one-year anniversary of the world's first personalized CRISPR gene therapy in February 2026. The hospital continues to expand, having opened a new inpatient facility in King of Prussia in 2022 and planning a new 24-story tower by 2028.